Skip to content

Study on Baroreceptor Function in Relation to Orthostatic Blood Pressure Regulation After Hip Surgery

Baroreceptor Function and Inflammation in Relation to Orthostatic Intolerance During Early Mobilization After Elective Hip Arthroplasty

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01866787
Enrollment
30
Registered
2013-05-31
Start date
2013-01-31
Completion date
2015-12-31
Last updated
2015-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension, Orthostatic, Total Hip Replacement

Keywords

Postoperative orthostatic intolerance, Surgical inflammatory response

Brief summary

The purpose of this observational study is to evaluate the baroreceptor function in relation to surgical inflammation and orthostatic intolerance after elective hip arthroplasty. The main hypothesis is that baroreceptor function is attenuated after surgery and related to surgical inflammation.

Detailed description

Orthostatic intolerance and hypotension is prevalent during early mobilization after major surgery. This observational study aims to evaluate the baroreceptor function during using a standardized evaluation protocol before, 6- and 24 hours after elective primary unilateral hip-arthroplasty. The study hypothesis is that baroreceptor function as expressed by the valsalva ratio is attenuated after surgery and related to surgical inflammation.

Interventions

None listed

Sponsors

Lundbeck Foundation
CollaboratorOTHER
Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Scheduled for unilateral hip arthroplasty * 18 years or older * Able to give informed consent

Exclusion criteria

* American Society of Anesthesiologists (ASA) class 3 or higher * Chronic arrythmia (Atrial fibrillation or other arrythmia) * Incompensated ischaemic heart disease * Mobilization restriction due to surgical reasons * Medical complications during admission requiring transferral to other department

Design outcomes

Primary

MeasureTime frameDescription
Change in baroreceptor function from preoperatively to 6 hours after surgery6 hours after surgeryChange in baroreceptor function as expressed by change in the blood pressure valsalva ratio during a standardized assessment before and 6 hours after surgery.

Secondary

MeasureTime frameDescription
Orthostatic response in heart rate variabilitypreoperative, 6 and 24 hours postoperativeHeart rate variability during supine rest, sitting and standing as assessed by Spectral analysis.
Orthostatic intolerancepreoperative, 6 and 24 hours after surgeryOrthostatic intolerance defined as the inability to sit or stand for 3 minutes due to presyncopal symptoms (Dizziness, Nausea, Blurred vision).
Orthostatic response in blood pressurePreoperative, 6 and 24 hours after surgeryThe response in systolic and diastolic blood pressure during postural change from supine to standing
Orthostatic HypotensionPreoperative, 6 and 24 hours postoperative.orthostatic hypotension defined according to international guidelines.
Baroreceptor functionOn the day of surgery: preoperatively, 6- and 24 hours after surgerybaroreceptor function as expressed by change in the blood pressure valsalva ratio during a standardized assessment
Inflammatory markerspreoperative, 6 and 24 hours postoperativeInflammatory markers (CRP and interleukin-6) measured at 3 separate timepoint: preoperative, 6- and 24 h after surgery

Countries

Denmark

Contacts

Primary ContactØivind Jans, M.D
oeivind.jans@regionh.dk

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026